Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Traci A Mansfield"'
Autor:
Nayyar Iqbal, Agata Ptaszynska, Kyung-Wan Min, Ping Han, Caroline T'joen, Bei Wang, Eva Johnsson, Traci A Mansfield, Wenying Yang
Publikováno v:
Journal of Diabetes. 8:796-808
Background Dapagliflozin, a highly selective sodium–glucose cotransporter 2 inhibitor, reduces hyperglycemia, body weight, and blood pressure in patients with type 2 diabetes (T2D). Methods This randomized double-blind placebo-controlled parallel-g
Autor:
Federica Alessi, Shamik Parikh, Traci A Mansfield, Michael A. Weber, Agata Ptaszynska, Nayyar Iqbal
Publikováno v:
Blood pressure. 25(2)
Hypertension and type 2 diabetes mellitus (T2DM) are risk factors for cardiovascular disease. Dapagliflozin improves glycemic control and systolic blood pressure (SBP) in T2DM patients. This double-blind phase III study evaluated the effects of dapag
Autor:
JF List, H Yeh, Nayyar Iqbal, A Ptaszynska, Jennifer Sugg, O Proske, Traci A Mansfield, A Katz, Shamik Parikh
Publikováno v:
Diabetologie und Stoffwechsel. 10
Autor:
Mary Jo Numerick, Kathleen I. MacKenzie, Bryan Goodwin, Guizhen Luo, Jane G Binz, Yaping Liu, Bhasha Desai, Steven A. Kliewer, Stacey A. Jones, Traci Ann Mansfield, Steve Dennis
Publikováno v:
Journal of Clinical Investigation. 112:1678-1687
Farnesoid X receptor (FXR) is a bile acid-activated transcription factor that is a member of the nuclear hormone receptor superfamily. Fxr-null mice exhibit a phenotype similar to Byler disease, an inherited cholestatic liver disorder. In the liver,
Autor:
Steven A. Kliewer, Traci Ann Mansfield, Stacey A. Jones, Bryan Goodwin, Karen F. Kozarsky, Mary H Donahee, Andrew N. Billin, Y. Yvette McNeill, Da Yuan Wang, John E. Bisi, Jason A. Holt, Guizhen Luo
Publikováno v:
Genes & Development. 17:1581-1591
The catabolism of cholesterol to bile acids represents a major pathway for the elimination of this potentially pathogenic sterol fromthe body. Bile acids subserve a number of important physiological functions, including the solubilization of choleste
Publikováno v:
Expert Review of Molecular Diagnostics. 2:337-345
The application of advanced modern biomedical and chemical research technologies in the pharmaceutical industry has led to a significant increase in the number of potential drug targets and lead candidates. Whereas the drug discovery process is enhan
Autor:
John C. Detter, Velizar T. Tchernev, A. Madan Kumar, Jonathan M. Rothberg, Margaret R. Wallace, Vishnu S. Mishra, Krishnan Nandabalan, Loic Giot, Traci A. Mansfield, Stephen F. Kingsmore, Frederick S. Southwick, Ying Li
Publikováno v:
Molecular Medicine. 8:56-64
BACKGROUND:Chediak-Higashi syndrome (CHS) is an inherited immunodeficiency disease characterized by giant lysosomes and impaired leukocyte degranulation. CHS results from mutations in the lysosomal trafficking regulator (LYST) gene, which encodes a 4
Publikováno v:
Circulation. 130
Hypertension (HTN) in Type 2 diabetes (T2D) is often treated with an ACEi/ARB + additional antihypertensives agents (AHTs). Dapagliflozin (DAPA) is an inhibitor of sodium glucose co-transporter 2, reducing hyperglycemia in T2D by increasing urinary g
Publikováno v:
Circulation. 130
Background: Hypertension is a common comorbidity in patients with type 2 diabetes mellitus (T2DM). Initial treatment is usually with an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB), with other antihypertensi
Publikováno v:
Diabetologie und Stoffwechsel. 9